PT88357A - Processo para a preparacao de novos derivados do acido 2-aza-biciclooctano-3-carboxilico - Google Patents

Processo para a preparacao de novos derivados do acido 2-aza-biciclooctano-3-carboxilico

Info

Publication number
PT88357A
PT88357A PT88357A PT8835788A PT88357A PT 88357 A PT88357 A PT 88357A PT 88357 A PT88357 A PT 88357A PT 8835788 A PT8835788 A PT 8835788A PT 88357 A PT88357 A PT 88357A
Authority
PT
Portugal
Prior art keywords
formula
derivative
see diagramm
iii
compound
Prior art date
Application number
PT88357A
Other languages
English (en)
Other versions
PT88357B (pt
Inventor
Michel Vincent
Georges Remond
Michel Laubie
Original Assignee
Obrecht Gary W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obrecht Gary W filed Critical Obrecht Gary W
Publication of PT88357A publication Critical patent/PT88357A/pt
Publication of PT88357B publication Critical patent/PT88357B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT88357A 1987-08-28 1988-08-26 Processo para a preparacao de novos derivados do acido 2-aza-biciclooctano-3-carboxilico PT88357B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712013A FR2619813B1 (fr) 1987-08-28 1987-08-28 Nouveaux derives de l'acide aza - 2 bicyclooctane carboxylique - 3, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
PT88357A true PT88357A (pt) 1989-06-30
PT88357B PT88357B (pt) 1995-03-31

Family

ID=9354475

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88357A PT88357B (pt) 1987-08-28 1988-08-26 Processo para a preparacao de novos derivados do acido 2-aza-biciclooctano-3-carboxilico

Country Status (16)

Country Link
US (1) US4959372A (pt)
EP (1) EP0305297B1 (pt)
JP (1) JPS6471875A (pt)
AT (1) ATE52789T1 (pt)
AU (1) AU612689B2 (pt)
CA (1) CA1327800C (pt)
DE (1) DE3860148D1 (pt)
DK (1) DK170978B1 (pt)
ES (1) ES2031616T3 (pt)
FR (1) FR2619813B1 (pt)
GR (1) GR3000677T3 (pt)
IE (1) IE60505B1 (pt)
NZ (1) NZ225943A (pt)
OA (1) OA08754A (pt)
PT (1) PT88357B (pt)
ZA (1) ZA886368B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655989B1 (fr) * 1989-12-20 1992-02-28 Adir Nouveaux derives d'amino-acides substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5458883A (en) * 1994-01-12 1995-10-17 Duke University Method of treating disorders of the eye
EP1233811A2 (en) * 1999-11-12 2002-08-28 Leo Rubin Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use
JPWO2002076981A1 (ja) * 2001-03-26 2004-10-07 壽製薬株式会社 イソキヌクリジン誘導体及びその製造方法並びにこれを含有する医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2492381A1 (fr) * 1980-10-21 1982-04-23 Science Union & Cie Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3227055A1 (de) * 1982-07-20 1984-01-26 Hoechst Ag, 6230 Frankfurt Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung

Also Published As

Publication number Publication date
FR2619813A1 (fr) 1989-03-03
ATE52789T1 (de) 1990-06-15
ZA886368B (en) 1989-05-30
DK170978B1 (da) 1996-04-09
DK472788D0 (da) 1988-08-24
FR2619813B1 (fr) 1991-05-03
DE3860148D1 (de) 1990-06-21
GR3000677T3 (en) 1991-09-27
CA1327800C (fr) 1994-03-15
NZ225943A (en) 1990-06-26
OA08754A (fr) 1989-03-31
AU612689B2 (en) 1991-07-18
DK472788A (da) 1989-03-01
AU2159488A (en) 1989-03-09
JPS6471875A (en) 1989-03-16
IE60505B1 (en) 1994-07-27
EP0305297A1 (fr) 1989-03-01
PT88357B (pt) 1995-03-31
IE882599L (en) 1989-02-28
ES2031616T3 (es) 1992-12-16
US4959372A (en) 1990-09-25
EP0305297B1 (fr) 1990-05-16

Similar Documents

Publication Publication Date Title
CA1260493A (en) Process for the preparation of phenylethanolaminotetralines, having lypolytic activity
KR960004858B1 (ko) 프롤리날 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
HU186594B (en) Process for the preparation of cis,endo-2-azabicyclo-square bracket-3.3.0-square bracket octan-3-carboxylic acids and pharmaceutical compositions containing said compounds
EP0198898A1 (en) DIPEPTIDE COMPOUNDS HAVING PHARMACEUTICAL ACTIVITY AND COMPOSITIONS CONTAINING SAME.
NO164536B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av cis, endo-2-azabicyklo-(5,3,0)-decan-3-karboksylsyre, samt mellomprodukter for anvendelse ved fremstilling derav.
KR910009712A (ko) 세펨 화합물 및 이의 제조방법
PL332640A1 (en) Sulphonamide-group substituted derivatives of aspartic acid as inhibitors of an interleukin-1beta transforming enzyme
PT91539B (pt) Processo para a preparacao de novos derivados peptidicos com accao antagonista do neuropeptido y
US4065566A (en) N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same
PT88357A (pt) Processo para a preparacao de novos derivados do acido 2-aza-biciclooctano-3-carboxilico
WO1988006448A1 (en) Prostaglandins useful for lowering intraocular pressure
JPH08502495A (ja) 新規な7−(5−置換−シクロペンチル)及び(5−置換−シクロペンテニル)ヘプチルアルコール、ヘプチルアミン及びヘプタン酸アミド、及びこれらの新規化合物の投与による哺乳類の眼球内圧を低下させる方法
MX172782B (es) Derivados de acidos aminocarboxilicos y biciclicos, procedimientos y productos intermediarios para su preparacion asi como su empleo
FR2605004A1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
HUT50342A (en) Process for producing n-/5,6,7,8-tetrahydropyrido(3,3-d) pyrimidin-6-yl-alkanoyl/-glutamic acid derivatives and pharmaceutical compositions comprising same
US3822268A (en) Lysergic acid amides
US4474795A (en) Enkephalinase inhibitors
US4474799A (en) Enkephalinase inhibitors
Vidal-Cros et al. Vitamin K-dependent carboxylation. Mechanistic studies with 3-fluoroglutamate-containing substrates
Chen et al. Synthesis of 2 (S)‐benzyl‐3‐[hydroxy (1′(R)‐amino ethyl) phosphinyl] propanoyl‐L‐3‐[125I]‐iodotyrosine: a radiolabelled inhibitor of aminopeptidase N
Waksman et al. Kelatorphan: A full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative
ES8506623A1 (es) Procedimiento de obtencion de nuevos derivados isoindolicos dicarboxilicos sustituidos.
EP0230179A3 (en) 4-morpholinyl 1h-indole derivatives, their salts, process and intermediates of preparation, use as therapeutic agents, compositions containing them
US4530933A (en) 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
FI84481B (fi) Foerfarande foer framstaellning av nya antihypertensiva 7-amino-1,2,3,4,6,7,8,12b-oktahydro-6-oxopyrido/2,1-a// 2/-bensazepin-4-karboxylsyraderivat.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940909

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980331